Store
The Market for RNA Sequencing, 2nd Edition
Publication Date: September 7, 2022
Tags: Clinical Diagnostics, Genetic Diseases, Hematology, Infectious Disease Testing Instruments, Next-Generation Sequencing (NGS), Next-Generation Sequencing (NGS) Systems, Oncology and Cancer, Sequencing, Sequencing Technologies
Pages: 55
SKU: 22-041
The sequencing market has continued to provide powerful tools that hold the promise of bringing major changes to healthcare in the near future. In the last decade, explosive growth has occurred in terms of product introductions, new applications, and the end-user labs rushing to participate in these new areas. In recent years, the use of microarrays for RNA expression analysis has dropped greatly as RNA sequencing has risen to replace and outshine it.
This Kalorama Information report, The Market for RNA Sequencing, 2nd Edition, offers a deep dive into the rapidly evolving RNA sequencing market, highlighting key trends, challenges, strategies, and competitive dynamics.
Report Highlights:
- Market Overview:
- An exploration of how the sequencing market is revolutionizing healthcare with powerful new tools.
- Analysis of the significant growth in product introductions, new applications, and the surge of end-user labs entering this dynamic field.
- Insight into the rise of RNA sequencing as it surpasses microarrays for RNA expression analysis and provides substantial advantages over traditional methods like q-RT-PCR.
- Advantages of RNA Sequencing:
- Improved sensitivity and dynamic range.
- Capability to study species without reference.
- Measurement of focal changes such as single nucleotide variants, insertions, and deletions.
- Detection of different transcript isoforms, splice variants, and chimeric gene fusions, including previously unidentified genes and transcripts.
Scope and Methodology:
- Market Segmentation:
- Detailed analysis of the RNA sequencing market, covering hardware, hardware services, software, and consumables.
- Examination of trends, challenges, strategies, and key products in the market.
- Market Size and Forecast:
- RNA Sequencing Market estimates for 2021 and 2026.
- RNA Sequencing Consumables Market projections for 2021 and 2026.
- RNA Sequencing Equipment-Related Services Market forecasts for 2021 and 2026.
- RNA Sequencing Software Market outlook for 2021 and 2026.
- Competitive Analysis:
- Market share analysis and revenue growth estimates for key vendors.
- Overview of products currently on the market, including software and clinical sequencing products.
- Discussion on innovations, competitive situations, deals, and litigation within the industry.
Table: RNA Sequencing Revenue Shares, by Market, 2021-2026 (%)
| Segment | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Consumables | XX% | XX% | XX% | XX% | XX% | XX% |
| Systems/ hardware | XX% | XX% | XX% | XX% | XX% | XX% |
| Service | XX% | XX% | XX% | XX% | XX% | XX% |
| Software | XX% | XX% | XX% | XX% | XX% | XX% |
| Total | XX% | XX% | XX% | XX% | XX% | XX% |
Source: Kalorama Information
For further details and to purchase directly, please contact us.
Table of Contents
Chapter 1: Executive Summary
- Table 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (in millions of $)
- Figure 1-1: RNA Sequencing Revenues by Product Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
Scope and Methodology
Report Structure
Chapter 2: Market Trends
Introduction
Trends
Clinical Diagnostics, Clinical Research Applications
Cancer – leukemia/ hematological diseases; solid tumors
Infectious diseases
Rare inherited/ genetic diseases
- Table 2-1: Selected RNA-Seq Diagnostic/ Clinical Products and Technologies
COVID-19
Illumina’s Diverse Range of Products
Other Companies’ NGS Products and Technologies
CDC’s SPHERES Consortium
Ongoing Introductions of New Products
- Table 2-2: RNA-Sequencing Product Introductions, August 2017- August 2022
Single-Cell RNA Sequencing
Selected Products/ Technologies
- Table 2-3: Selected RNA-Seq Products and Technologies
Software/ Bioinformatics
- Table 2-4: Selected RNA-Seq Software and Related IT Tools
Partnerships, Acquisitions, Deals in Many Areas
- Table 2-5: RNA-Seq Collaborations, Acquisitions and Other Deals
Chapter 3: Market Analysis
Market Analysis
- Table 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
- Figure 3-1: RNA Sequencing Revenues, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (in millions of dollars)
- Table 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021-2026 (percent)
- Figure 3-2: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2021 (percent)
- Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
Market Shares
- Table 3-3: RNA Sequencing Market Revenue Share, by Leading Companies (Illumina, Thermo, and Other), 2021 (millions of dollars and percent)
- Figure 3-3: RNA Sequencing Revenue Shares, by Market Segment (Consumables, Systems/Hardware, Service, and Software), 2026 (percent)
- Table 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (millions of dollars and percent)
- Figure 3-4: RNA Sequencing Market Revenue Share, by Region (North America, Europe, APAC, and Rest of World), 2021 (percent)
Chapter 4: Company Profiles
Illumina
Thermo Fisher Scientific
New England Biolabs
10X Genomics
Agilent Technologies
Takara Bio Inc.
Oxford Nanopore Technologies
NuGen (Tecan)
Pacific Biosciences of California, Inc. (PacBio)
Standard BioTools
Related products
Cell and Gene Therapy Market and Deals Analysis, 2023
May 22, 2023
Cell and Gene Therapy Market and Deals Analysis, 2023: Financings, Partnering, Mergers and Acquisitions, Tech Transfers, IPOs, and Other Deals tracks deal-making and market opportunities in cell and gene therapy, providing specific details of 1000+ deals from 2022-2023. With a staggering $40 billion in CGT deals in 2022 alone, understanding the market dynamics and key…
$4,000.00 – $6,000.00
The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition
April 23, 2024
Explore the latest trends and forecasts in the point-of-care (POC) diagnostic tests market with Kalorama Information’s The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 11th Edition. Discover the key growth areas and technological advancements shaping the future of POC diagnostics.
Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in…
$7,000.00 – $10,000.00
Cell Therapy and Gene Therapy Disease Markets, 2023-2029
April 30, 2024
Explore the future of medicine with our in-depth report on cell therapy, gene therapy, and RNA therapy markets. Cell therapy and gene therapy represent a frontier in modern medicine, promising revolutionary treatments by treating the underlying genetic causes of disease and by genetically controlling the body’s immune system. Recent years have seen an increase in…
$5,000.00 – $7,875.00
